CAT vs EBS
Caterpillar Inc (CAT) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CAT and EBS stock pages for the full models.
Not investment advice.